BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29728568)

  • 1. Egr2-independent, Klf1-mediated induction of PD-L1 in CD4
    Teruya S; Okamura T; Komai T; Inoue M; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Sci Rep; 2018 May; 8(1):7021. PubMed ID: 29728568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Growth Response Gene 2-Expressing CD4
    Okamura T; Yamamoto K; Fujio K
    Front Immunol; 2018; 9():340. PubMed ID: 29535721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
    Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1
    Symonds AL; Zheng W; Miao T; Wang H; Wang T; Kiome R; Hou X; Li S; Wang P
    Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32709717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.
    Okamura T; Fujio K; Shibuya M; Sumitomo S; Shoda H; Sakaguchi S; Yamamoto K
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13974-9. PubMed ID: 19666526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tonsillar CD4
    Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
    J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.
    Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y
    Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The functions of CD4+CD25-LAG3+ regulatory T cells and Egr2 in the regulation of autoimmunity].
    Fujio K; Okamura T; Sumitomo S; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(2):69-73. PubMed ID: 24835133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Egr2 regulation in T cells is mediated through IFNγ/STAT1 and IL-6/STAT3 signalling pathway.
    Taefehshokr N; Miao T; Symonds ALJ; Wang P; Li S
    Pathol Res Pract; 2020 Dec; 216(12):153259. PubMed ID: 33099163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
    Casella G; Rasouli J; Thome R; Descamps HC; Vattikonda A; Ishikawa L; Boehm A; Hwang D; Zhang W; Xiao D; Park J; Zhang GX; Alvarez JI; Rostami A; Ciric B
    Front Immunol; 2020; 11():576752. PubMed ID: 33193372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
    Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
    J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.